Disclosed are compositions comprising substituted nitrostyrene compounds, as well as methods for their manufacture. Also disclosed are methods of using these compounds in the treatment and/or amelioration of symptoms of bacterial infections such as those caused by Staphylococcus app. (including vancomycin-resistant strains of S. aureus) and Enterococcal spp.